FoRx Therapeutics discloses its Board with Dr Colin Goddard as Executive Chairman and announces €10m seed financing led by M Ventures, Novartis Venture Fund and Omega Funds

– SWITZERLAND, Basel –  FoRx Therapeutics AG, the biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress (DRS) pathways, today announced the closing of a EUR 10 million seed financing led by M Ventures, Novartis Venture Fund and Omega Funds.

Immunitas Therapeutics discloses its Board of Directors along with launching with $39m Series A financing led by Leaps by Bayer and Novartis Venture Fund

– USA, MA –  Immunitas Therapeutics, a single cell genomics-based drug discovery company founded by Longwood Fund, today announced a $39 million Series A financing led by Leaps by Bayer and Novartis Venture Fund and joined by additional investors including Evotec, M Ventures, Alexandria Venture Investments, and other institutional investors.…